International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003–2012

Annals of Clinical Microbiology and Antimicrobials

Research

Fatma Sirmatel¹  Ata Nevzat Yalcin²  A Pekcan Demiroz³  Özay Arikan Akan⁴  Mehmet Bakir⁵  Begüm Atasay⁶  Tanil Kendirli⁷  Davut Ozdemir⁸  Sercan Ulusoy⁹  Emine Alp^1,10  Nurettin Erben^1,11  Nilgün Altin^1,12  Dilek Arman^1,13  Cengiz Uzun^1,14  Oral Oncul^1,15  Serhat Unal^1,16  Asu Özgültekin^1,17  Victor Daniel Rosenthal^1,18  Iftihar Koksal^1,19  Ayse Willke^2,20  Halil Özdemir^2,21  Gülden Ersöz^2,22  Canan Aygun^2,23  Hakan Leblebicioglu^2,24  Alper Sener^2,25  Huseyin Turgut^2,26  Nazan Tuna^2,27  Gunes Senol^2,28  Ayse Erbay^2,29  Dinçer Yıldızdaş^3,30 

[1] Abant Izzet Baysal University, Bolu, Turkey;Akdeniz University, Antalya, Turkey;Ankara Training and Research Hospital, Ankara, Turkey;Ankara University School of Medicine Ibni-Sina Hospital, Ankara, Turkey;Cumhuriyet University School of Medicine, Sivas, Turkey;Department of Newborn Medicine, Ankara University School of Medicine, Faculty of Paediatrics, Ankara, Turkey;Department of Paediatric Critical Care Medicine, Ankara University School of Medicine, Ankara, Turkey;Duzce University Medical School Infectious Diseases and Clinical Microbiology, Duzce, Turkey;Ege University Medical Faculty, Izmir, Turkey;Erciyes University, Faculty of Medicine, Kayseri, Turkey;Eskisehir Osmangazi University, Eskisehir, Turkey;Etlik İhtisas Training and Education Hospital, Ankara, Turkey;Gazi University Medical School, Ankara, Turkey;German Hospital, Istanbul, Turkey;Gulhane Military Medical Academy, Haydarpasa Training Hospital, Istanbul, Turkey;Hacettepe University School of Medicine, Ankara, Turkey;Haydarpaşa Numune Training and Research Hospital, Istanbul, Turkey;International Nosocomial Infection Control Consortium, Ave # 4580, Floor 12, Apt D, 1195, Corrientes, Buenos Aires, Argentina;Karadeniz Technical University School of Medicine, Trabzon, Turkey;Kocaeli University Faculty of Medicine, Kocaeli, Turkey;Konya Training and Research Hospital, Konya, Turkey;Mersin University, Faculty of Medicine, Mersin, Turkey;Ondokuz Mayis University Medical School (Neonatal Unit), Samsun, Turkey;Ondokuz Mayis University Medical School, Samsun, Turkey;Onsekiz Mart University Canakkale, Canakkale, Turkey;Pamukkale University, Denizli, Turkey;Sakarya Universty, Faculty of Medicine, Sakarya, Turkey;Suat Seren Chest Diseases and Chest Surgery Training Hospital, Izmir, Turkey;Turkiye Yuksek Ihtisas Education and Research Hospital, Ankara, Turkey;Çukurova University Balcali Hospital, Adana, Turkey;

关键词: Hospital infection;    Nosocomial infection;    Healthcare-associated infection;    INICC;    International Nosocomial Infection Consortium;    Turkey;    Device-associated infection;    Antibiotic resistance;    Ventilator-associated pneumonia;    Catheter-associated urinary tract infection;    Central line-associated bloodstream infections;    Bloodstream infection;    Urinary tract infection;    Network;   

DOI  :  10.1186/s12941-014-0051-3

 received in 2014-04-29, accepted in 2014-10-24,  发布年份 2014

来源: Springer

【 摘 要 】

BackgroundDevice-associated healthcare-acquired infections (DA-HAI) pose a threat to patient safety, particularly in the intensive care unit (ICU). We report the results of the International Infection Control Consortium (INICC) study conducted in Turkey from August 2003 through October 2012.MethodsA DA-HAI surveillance study in 63 adult, paediatric ICUs and neonatal ICUs (NICUs) from 29 hospitals, in 19 cities using the methods and definitions of the U.S. NHSN and INICC methods.ResultsWe collected prospective data from 94,498 ICU patients for 647,316 bed days. Pooled DA-HAI rates for adult and paediatric ICUs were 11.1 central line-associated bloodstream infections (CLABSIs) per 1000 central line (CL)-days, 21.4 ventilator-associated pneumonias (VAPs) per 1000 mechanical ventilator (MV)-days and 7.5 catheter-associated urinary tract infections (CAUTIs) per 1000 urinary catheter-days. Pooled DA-HAI rates for NICUs were 30 CLABSIs per 1000 CL-days, and 15.8 VAPs per 1000 MV-days. Extra length of stay (LOS) in adult and paediatric ICUs was 19.4 for CLABSI, 8.7 for VAP and 10.1 for CAUTI. Extra LOS in NICUs was 13.1 for patients with CLABSI and 16.2 for patients with VAP. Extra crude mortality was 12% for CLABSI, 19.4% for VAP and 10.5% for CAUTI in ICUs, and 15.4% for CLABSI and 10.5% for VAP in NICUs. Pooled device use (DU) ratios for adult and paediatric ICUs were 0.54 for MV, 0.65 for CL and 0.88 for UC, and 0.12 for MV, and 0.09 for CL in NICUs. The CLABSI rate was 8.5 per 1,000 CL days in the Medical Surgical ICUs included in this study, which is higher than the INICC report rate of 4.9, and more than eight times higher than the NHSN rate of 0.9. Similarly, the VAP and CAUTI rates were higher compared with U.S. NHSN (22.3 vs. 1.1 for VAP; 7.9 vs. 1.2 for CAUTI) and with the INICC report (22.3 vs. 16.5 in VAP; 7.9 vs. 5.3 in CAUTI).ConclusionsDA-HAI rates and DU ratios in our ICUs were higher than those reported in the INICC global report and in the US NHSN report.

【 授权许可】

Unknown   
© Leblebicioglu et al.; licensee BioMed Central Ltd. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.